Insurers

Kevin Herwig discussed alternative funding programs at the National Intellectual Property Rights Coordination’s Pharmaceutical Symposium, highlighting the harms of these schemes which delay or block access to life-saving drugs, and often try to force patients to obtain life-saving medications through illegal importation. He urged government regulators to take action to enforce the law, investigate AFP business practices, and close the loopholes that enable them to operate.